TNAT-101

N/A

Report date: 2024/12/20 15:58:11
NME

Base Information

Drug NameTNAT-101
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBCL3 Transcription Coactivator inhibitors
TargetsBCL3 Transcription Coactivator
Therapy Area/IndicationsColorectal NeoplasmsTriple Negative Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTNA Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesTNA Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsColorectal NeoplasmsTriple Negative Breast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A